Asset Dedication LLC’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Asset Dedication LLC's ADPT Position: Q2 2026 in Review
Asset Dedication LLC held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 350 shares worth $7.51K. The position accounts for ﹤0.01% of the portfolio, ranked #834.
Asset Dedication LLC first reported a position in ADPT in Q2 2020 and has held it in 25 quarters since. The position peaked at $51K in Q2 2021. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.
- Asset Dedication LLC held 350 shares of Adaptive Biotechnologies worth $7.51K as of Q2 2026.
- Asset Dedication LLC left its Adaptive Biotechnologies share count unchanged in Q2 2026.
- Adaptive Biotechnologies made up ﹤0.01% of Asset Dedication LLC's portfolio in Q2 2026, its #834 holding.
- Asset Dedication LLC first reported a position in Adaptive Biotechnologies in Q2 2020 and has held it in 25 quarters since.
- Asset Dedication LLC's Adaptive Biotechnologies position peaked at $51K in Q2 2021.
- 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.
Based on Asset Dedication LLC's 13F filing for Q2 2026, filed 30 Jul 2026.